Navigation Links
Chances of Survival for Melanoma is High When Detected by Dermatologists

a non-dermatologist. Tumors diagnosed by dermatologists were thinner on average than those diagnosed by non-dermatologists (.86 millimeters vs. 1 millimeter). "We also looked at melanoma stage at diagnosis and observed significant differences between provider types, with a preponderance of thin melanoma (stage zero, or stage I or II) in the dermatologist group and a preponderance of thick melanoma (stage III or stage IV) in the non-dermatologist group," the authors write.

After six months, two years and five years, patients whose cancer was diagnosed by a dermatologist had a higher survival rate than those diagnosed by a non-dermatologist. "The two-year and five-year survival rates were 86.5 percent and 73.9 percent for the dermatologist group compared with 78.8 percent and 68.7 percent for the non-dermatologist group," the authors write. "When looking at the mortality rates by cause of death, both groups had similar non-cancer–related mortality rates. However, the dermatologist group had lower cancer-related mortality rates and a lower overall mortality rate."

Patients who visited dermatologists most likely had higher survival rates because their tumors were thinner and detected earlier, the authors note. "Although the difference between a melanoma that is .86 millimeters thick and one that is 1 millimeter thick does not correlate with different clinical stages, tumor thickness is a powerful predictor of patient survival and a likely driver of the outcomes we observed," the authors write.

"These results suggest that increasing access to dermatologists, particularly for older patients who have higher rates of melanoma, may represent one approach to improving melanoma-related health outcomes from a health policy perspective," the authors conclude.

Source-Eurekalert
SM
'"/>




Page: 1 2

Related medicine news :

1. Chances are high for Avian Influenza virus altering its form
2. Obesity Can Increase The Chances Of Injuries
3. Going Down The Social Ladder Increases The Chances Of Male Depression.
4. Gum Disease Increases Chances Of Pre-Term Birth
5. Fertility Treatment Offered During Summer Has Better Chances For Success
6. Dummies Serve To Reduce Chances Of SIDS
7. Vitamin D Reduces Chances of Colon, Breast And Ovarian Cancers by 50%
8. Chances Of Getting Cancer Can Be Reduced By Hysterectomy
9. Face Transplant Patient Jeopardizing Chances of Recovery By Smoking
10. Mental Activity Reduces Chances Of Dementia
11. Smoking Increases Chances Of Needing Root Canal Treatment
Post Your Comments:
(Date:8/31/2015)... ... , ... The Lisle family law firm of Momkus McCluskey, LLC ... peers to earn a “Leading Lawyers” distinction. , The “Leading Lawyers” ... Illinois. The nomination process is based on statewide peer survey nominations and the approval ...
(Date:8/31/2015)... ... August 31, 2015 , ... Patients who thought about getting a hair ... in learning more about the procedure beyond the information found on the Internet can ... transplant surgeon Parsa Mohebi will be on hand to answer patients hair transplant questions ...
(Date:8/31/2015)... ... 2015 , ... Neuropsychiatric Disease and Treatment has ... near-infrared laser phototherapy ”. , As corresponding author Dr Theodore Henderson says “These ... with mostly palliative treatments only - and now we have shown real clinical ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dr. Paul Kovatis of ... Doc.” , At OSSMC, Dr. Kovatis treats all surgical and non-surgical disorders of the ... to the entire musculoskeletal system, excluding the spine. , Dr. Paul Kovatis completed his ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... marketing communications company announced today that it has officially launched a new website ... new website and brand refresh are more closely aligned with the company’s strategic ...
Breaking Medicine News(10 mins):Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2Health News:Watch a Live Hair Transplant at Parsa Mohebi Hair Restoration’s Open House 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 3Health News:NJ Top Docs Presents, Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center on his Five Year Anniversary as an "NJ Top Doc" 2Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3
... the management of breast ... BRIDGEWATER, N.J., Dec. 7 Among the 62 oral,abstracts ... Symposium (SABCS), six with Taxotere(R) (docetaxel) Injection,Concentrate investigational regimens will ... Lecture 1 on the opening day of the symposium will ...
... - How do the lifestyle choices we make ... the American Association for Cancer Researchs Sixth Annual ... being held from December 5 to 8 in ... questions regarding daily decisions in diet, exercise, smoking ...
... eating four or more servings of green salad a week ... smokers and nonsmokers alike may be able to substantially reduce ... University of Texas M. D. Anderson Cancer Center. , "This ... of diet and physical activity on the possibility of developing ...
... Studies find effects on breast, prostate and colorectal tumors ... diabetes -- risk factors so often linked to heart ... of cancer, a collection of four new studies suggests. ... for Cancer Research,s Sixth Annual International Conference on the ...
... Data on Perifosine in the Treatment of Patients ... on Saturday, December 8th at 5:30pm, NEW ... KERX ) today announced that abstracts related to ... poster sessions,scheduled to take place at the upcoming ...
... The teams of Eric Le Cam, from,the ... - Institut Gustave,Roussy/CNRS/Universite Paris Sud) and David ... and Pathological Biomolecules - SABNP" lab,(Inserm/Universite d,Evry-Val-d,Essonne, ... method for observing DNA using atomic force,microscopy ...
Cached Medicine News:Health News:New Taxotere(R) (docetaxel) Injection Concentrate Data to be Presented at the 30th Annual San Antonio Breast Cancer Symposium (SABCS) 2Health News:New Taxotere(R) (docetaxel) Injection Concentrate Data to be Presented at the 30th Annual San Antonio Breast Cancer Symposium (SABCS) 3Health News:New Taxotere(R) (docetaxel) Injection Concentrate Data to be Presented at the 30th Annual San Antonio Breast Cancer Symposium (SABCS) 4Health News:New Taxotere(R) (docetaxel) Injection Concentrate Data to be Presented at the 30th Annual San Antonio Breast Cancer Symposium (SABCS) 5Health News:Lifestyle and cancer prevention: Making choices that change cancer risk 2Health News:Lifestyle and cancer prevention: Making choices that change cancer risk 3Health News:Lifestyle and cancer prevention: Making choices that change cancer risk 4Health News:Lifestyle and cancer prevention: Making choices that change cancer risk 5Health News:Lifestyle and cancer prevention: Making choices that change cancer risk 6Health News:M. D. Anderson research links diet, gardening and lung cancer risk 2Health News:Obesity, Diabetes Linked to Cancers 2Health News:Obesity, Diabetes Linked to Cancers 3Health News:Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia 2Health News:Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia 3Health News:Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia 4Health News:Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia 5Health News:Major Advance in the Observation of DNA Molecules 2
(Date:8/31/2015)... 31, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: ... field of regenerative medicine, today announced that the ... Chicago -based Rush University Medical Center in ... escalating doses of AST-OPC1 (oligodendrocyte progenitor cells) in ... cervical spinal cord injury (SCI). This represents the ...
(Date:8/31/2015)... 2015   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade cell and tissue ... media and a related cloud hosted ... smart shippers ("BioLife" or the "Company"), today ... biopharmaceutical company focused on developing and commercializing novel ...
(Date:8/28/2015)... , Aug. 28, 2015  With the heroin ... reaching deadlier heights, Jacksonville -based Lakeview ... Hemphill is helping to explain why fentanyl is ... approximately 40 to 50 times more potent than pharmaceutical ... users as heroin, the risk of death skyrockets. ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2
... (OTCQX: DATA), a technology and services company focused on global ... its Vice President of Research and Development, Chris Wilke, has ... 2009 Society for Clinical Data Management (SCDM) Annual Conference which ... Mr. Wilke will be discussing Is 100% EDC Realistic? ...
... ThermalTherapeutic Systems, Inc., developers of a highly ... today the completion of $2.75 Million Series A ... funding by the Pittsburgh Life Sciences Greenhouse, and ... investments by the Pittsburgh Life Sciences Greenhouse and ...
Cached Medicine Technology:DATATRAK to Present at 2009 SCDM Annual Conference 2DATATRAK to Present at 2009 SCDM Annual Conference 3ThermalTherapeutic Systems Completes $2.75 Million Series A Financing With Originate Ventures 2
The Natural Selection family of specialty allografts is spinal concepts response to surgeon requests for spinal allograft devices to eliminate the need for painful autograft harvesting....
Transcranial vascular DWL doppler....
Transcranial vascular DWL doppler....
... Neurocare is a full-featured physiologic testing system offered ... contains many of the features of our flagship ... economical price. , ,The smaller size of the ... environment, the physician's office, a mobile service or ...
Medicine Products: